Molecular epidemiology of genetic susceptibility to gastric cancer: Focus on single nucleotide polymorphisms in gastric carcinogenesis

American Journal of Translational Research

Volumn 1, Issue 1, 2009, Pages 44-54

  Yin, Ming ^a   Hu, Zhibin ^a   Tan, Dongfeng ^a   Ajani, Jaffer A ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Gastric cancer; Genetic polymorphism; Meta analysis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; XRCC1 PROTEIN;

CANCER INHIBITION; CANCER RISK; CATALYSIS; DNA REPAIR; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HELICOBACTER INFECTION; HUMAN; INCIDENCE; INFLAMMATION; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE METABOLISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; STOMACH CARCINOGENESIS;

HELICOBACTER PYLORI;

EID: 77953377743     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Parkin DM, Bray F, Ferlay J and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Haenszel W and Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 40: 43-68.
3. Buell P and Dunn JE, Jr. Cancer Mortality among Japanese Issei and Nisei of California. Cancer 1965; 18: 656-664.
4. McMichael AJ, McCall MG, Hartshorne JM and Woodings TL. Patterns of gastro-intestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer 1980; 25: 431-437.
5. Kelley JR and Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9.
6. Stock M and Otto F. Gene deregulation in gastric cancer. Gene 2005; 360: 1-19.
7. Hu Z, Ma H, Chen F, Wei Q and Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 1810-1818.
8. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001; 48: 743-747.
9. Zhang D, Zheng H, Zhou Y, Tang X, Yu B and Li J. Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer 2007; 7: 45.
10. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147.
11. Arend WP, Malyak M, Guthridge CJ and Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998; 16: 27-55.
12. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY and Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-1803.
13. Danis VA, Millington M, Hyland VJ and Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-310.
14. Santtila S, Savinainen K and Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998; 47: 195-198.
15. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Jr. and Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
16. Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina-Menchaca R, Maldonado-Garza HJ and Perez-Perez GI. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005; 114: 237-241.
17. Lee SG, Kim B, Choi W, Lee I, Choi J and Song K. Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B -31 C/+ and IL-1RN *2/*2) and gastric cancer/duodenal ulcer in Korean population. Cytokine 2003; 21: 167-171.
18. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT and Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003; 104: 617-623.
19. Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S and Matsukura N. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais. J Gastroenterol 2006; 41: 1169-1177.
20. Wang P, Xia HH, Zhang JY, Dai LP, Xu XQ and Wang KJ. Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer 2007; 120: 552-562.
21. Camargo MC, Mera R, Correa P, Peek RM, Jr., Fontham ET, Goodman KJ, Piazuelo MB, Sicinschi L, Zabaleta J and Schneider BG. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1674-1687.
22. Kamangar F, Cheng C, Abnet CC and Rabkin CS. Interleukin-1B polymorphisms and gastric cancer risk - a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1920-1928.
23. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ and Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-429.
24. Beales IL and Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42: 227-234.
25. Wolfe MM and Nompleggi DJ. Cytokine inhibition of gastric acid secretion - a little goes a long way. Gastroenterology 1992; 102: 2177-2178.
26. Kroeger KM, Carville KS and Abraham LJ. The - 308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
27. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H and Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51: 605-612.
28. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Jr. and Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201.
29. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, Van Doorn LJ, Caldas C, Seruca R, Carneiro F and Sobrinho-Simoes M. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-371.
30. Glas J, Torok HP, Schneider A, Brunnler G, Kopp R, Albert ED, Stolte M and Folwaczny C. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol 2004; 22: 4746-4752.
31. Lu W, Pan K, Zhang L, Lin D, Miao X and You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26: 631-636.
32. Perri F, Piepoli A, Bonvicini C, Gentile A, Quitadamo M, Di Candia M, Cotugno R, Cattaneo F, Zagari MR, Ricciardiello L, Gennarelli M, Bazzoli F, Ranzani GN and Andriulli A. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine 2005; 30: 293-302.
33. Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, Pietinen P, Dawsey SM, Albanes D, Virtamo J and Taylor PR. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006; 17: 117-125.
34. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS and Paik KH. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001; 166: 41-46.
35. Zhang J, Dou C, Song Y, Ji C, Gu S, Xie Y and Mao Y. Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis. J Hum Genet 2008; 53: 479-489.
36. Gorouhi F, Islami F, Bahrami H and Kamangar F. Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer 2008; 98: 1443-1451.
37. Ozawa N and Guengerich FP. Evidence for formation of an S-2-(N7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of the carcinogen 1,2-dibromoethane to DNA. Proc Natl Acad Sci U S A 1983; 80: 5266-5270.
38. Grant DM, Josephy PD, Lord HL and Morrison LD. Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines. Cancer Res 1992; 52: 3961-3964.
39. Kaderlik KR, Mulder GJ, Turesky RJ, Lang NP, Teitel CH, Chiarelli MP and Kadlubar FF. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. Carcinogenesis 1994; 15: 1695-1701.
40. Boberg EW, Miller EC, Miller JA, Poland A and Liem A. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Res 1983; 43: 5163-5173.
41. Weisburger JH and Raineri R. Dietary factors and the etiology of gastric cancer. Cancer Res 1975; 35: 3469-3474.
42. Guengerich FP, Kim DH and Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991; 4: 168-179.
43. Yang CS and Smith TJ. Mechanisms of nitrosamine bioactivation and carcinogenesis. Adv Exp Med Biol 1996; 387: 385-394.
44. Botto F, Seree E, el Khyari S, de Sousa G, Massacrier A, Placidi M, Cau P, Pellet W, Rahmani R and Barra Y. Tissue-specific expression and methylation of the human CYP2E1 gene. Biochem Pharmacol 1994; 48: 1095-1103.
45. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270: 414-423.
46. Raucy JL, Kraner JC and Lasker JM. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol 1993; 23: 1-20.
47. Kim RB, Yamazaki H, Chiba K, O'Shea D, Mimura M, Guengerich FP, Ishizaki T, Shimada T and Wilkinson GR. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther 1996; 279: 4-11.
48. Hayashi S, Watanabe J and Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991; 110: 559-565.
49. Boccia S, De Lauretis A, Gianfagna F, van Duijn CM and Ricciardi G. CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature. Carcinogenesis 2007; 28: 101-106.
50. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6: 733-743.
51. Bolt HM and Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 2006; 7: 613-628.
52. Obst B, Wagner S, Sewing KF and Beil W. Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis 2000; 21: 1111-1115.
53. Nan HM, Song YJ, Yun HY, Park JS and Kim H. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol 2005; 11: 3834-3841.
54. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, Wild N, Leopard P, Bell DA, Jones P, Duncan H, Brannigan K, Alldersea J, Fryer AA and Strange RC. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 1996; 17: 881-884.
55. Kato S, Onda M, Matsukura N, Tokunaga A, Matsuda N, Yamashita K and Shields PG. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study. Cancer 1996; 77: 1654-1661.
56. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, Ookuma R and Bell DA. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996; 17: 1855-1859.
57. Oda Y, Kobayashi M, Ooi A, Muroishi Y and Nakanishi I. Genotypes of glutathione S-transferase M1 and N-acetyltransferase 2 in Japanese patients with gastric cancer. Gastric Cancer 1999; 2: 158-164.
58. Cai L, Yu SZ and Zhang ZF. Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study. World J Gastroenterol 2001; 7: 506-509.
59. Lan Q, Chow WH, Lissowska J, Hein DW, Buetow K, Engel LS, Ji B, Zatonski W and Rothman N. Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics 2001; 11: 655-661.
60. Saadat I and Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett 2001; 169: 21-26.
61. Wu MS, Chen CJ, Lin MT, Wang HP, Shun CT, Sheu JC and Lin JT. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis 2002; 17: 338-343.
62. Sgambato A, Campisi B, Zupa A, Bochicchio A, Romano G, Tartarone A, Galasso R, Traficante A and Cittadini A. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res 2002; 22: 3647-3652.
63. Choi SC, Yun KJ, Kim TH, Kim HJ, Park SG, Oh GJ, Chae SC, Oh GJ, Nah YH, Kim JJ and Chung HT. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett 2003; 195: 169-175.
64. Lai KC, Chen WC, Tsai FJ, Li SY, Chou MC and Jeng LB. Glutathione S-transferase M1 gene null genotype and gastric cancer risk in Taiwan. Hepatogastroenterology 2005; 52: 1916-1919.
65. Shen J, Wang RT, Xu YC, Wang LW and Wang XR. Interaction models of CYP1A1, GSTM1 polymorphisms and tobacco smoking in intestinal gastric cancer. World J Gastroenterol 2005; 11: 6056-6060.
66. Li H, Chen XL and Li HQ. Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol 2005; 11: 5757-5762.
67. Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, Setiawan VW, Zhou XF, Ding BG, Wang RH, Zhao J, Cai L, Rao JY, Heber D and Zhang ZF. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 2005; 116: 972-983.
68. Palli D, Saieva C, Gemma S, Masala G, Gomez-Miguel MJ, Luzzi I, D'Errico M, Matullo G, Ozzola G, Manetti R, Nesi G, Sera F, Zanna I, Dogliotti E and Testai E. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk italian population. Int J Cancer 2005; 115: 284-289.
69. Tamer L, Ates NA, Ates C, Ercan B, Elipek T, Yildirim H, Camdeviren H, Atik U and Aydin S. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct 2005; 23: 267-272.
70. Martins G, Alves M, Dias J, Santos R, Neves BC, Mafra M, Martins Ap, Ramos S, Ramos M, Mexia J, Quina M, Rueff J and Monteiro. C. Glutathione S transferase mu polymorphism and gastric cancer in the Portuguese population. Biomarkers 1998; 3: 441-447.
71. Jiang YH, Ju ZY, Ren CS, Lv QJ and Wei W. Study on the Relationship between the Glutathiones-transferase Gene Deletion Environmental Factors and susceptibility to Gastric Carcinoma. Chin J Public Health 2000; 16: 877-879.
72. Liu Y, Xu RT, Sun GF, Shang XL and Wang Y. The Relationship of GSTM1 Gene Homozygous Deletion Polymorphism and Occurrence of Gastric Cancer. J Chin Med univ 2000; 29: 287-289.
73. Gao CM, Takezaki T, Wu JZ, Li ZY, Liu YT, Li SP, Ding JH, Su P, Hu X, Xu TL, Sugimural H and Tajima K. Glutathione-S-transferase M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case-control study of high-incidence area in Jiangsu Province, China. Cancer Lett 2002; 188: 95-102.
74. Zheng TR, Zheng QH, Gong FS, Xie YQ and Wang XR. Gene deletion polymorphisms of GSTT1 and GSTM1 and susceptibility to stomach neoplasm. Shi Yong Zhong Liu Xue Za Zhi 2002; 17: 155-157.
75. Gong L, Sun HL and Xu YQ. The Study of Coorelations between the Deletion of GSTM1 Gene and Gastric Cancer. Wan Nan Yi Xue Yuan Xue Bao 2002; 21: 181-183.
76. Zhang YC, Deng CS, Zhou Y and Zhu YQ. Association of glutathione Stransferase M1 and T1 genetic polymorphisms with Helicobacter pylori infection an gastric adenocarcinoma. Shi Jie Hua Ren Xiao Hua Za Zhi 2003; 11: 1306-1309.
77. Shen XB, Zhang J, Zhu LJ and Pu YP. Relationship between Glutathione S-transferase M1, T1 genetic polymorphisms, smoking and alcohol consumption and susceptibility to stomach cancer. J Environ Health 2004; 21: 210-214.
78. Kobayashi M, Tsubono Y, Sasazuki S, Sasaki S and Tsugane S. Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I. Int J Cancer 2002; 102: 39-44.
79. Terry P, Nyren O and Yuen J. Protective effect of fruits and vegetables on stomach cancer in a cohort of Swedish twins. Int J Cancer 1998; 76: 35-37.
80. Pogribny IP, Basnakian AG, Miller BJ, Lopatina NG, Poirier LA and James SJ. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res 1995; 55: 1894-1901.
81. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB and Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997; 94: 3290-3295.
82. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 1999; 55: 578-592.
83. Choi SW, Kim YI, Weitzel JN and Mason JB. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998; 43: 93-99.
84. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG and Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 1994; 7: 551.
85. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP and et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
86. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051.
87. Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 2006; 51: 618-624.
88. Caldecott KW, Tucker JD, Stanker LH and Thompson LH. Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells. Nucleic Acids Res 1995; 23: 4836-4843.
89. Dianov GL, Prasad R, Wilson SH and Bohr VA. Role of DNA polymerase beta in the excision step of long patch mammalian base excision repair. J Biol Chem 1999; 274: 13741-13743.
90. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, Wang X, Spitz MR and Wei Q. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 2000; 88: 601-606.
91. Lee SG, Kim B, Choi J, Kim C, Lee I and Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett 2002; 187: 53-60.
92. Huang WY, Chow WH, Rothman N, Lissowska J, Llaca V, Yeager M, Zatonski W and Hayes RB. Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis 2005; 26: 1354-1359.
93. Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D and Silva AE. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol 2005; 11: 6593-6600.
94. Ratnasinghe LD, Abnet C, Qiao YL, Modali R, Stolzenberg-Solomon R, Dong ZW, Dawsey SM, Mark SD and Taylor PR. Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett 2004; 216: 157-164.
95. Dumont P, Leu JI, Della Pietra AC, 3rd, George DL and Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357-365.
96. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, Crook T and Lu X. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 2006; 38: 1133-1141.
97. Siddique M and Sabapathy K. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene 2006; 25: 3489-3500.
98. Pietsch EC, Humbey O and Murphy ME. Polymorphisms in the p53 pathway. Oncogene 2006; 25: 1602-1611.
99. Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K and Chayama K. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 2002; 100: 304-308.
100. Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J and Wei Q. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep 2004; 11: 1115-1120.
101. Wu MT, Chen MC and Wu DC. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett 2004; 205: 61-68.
102. Perez-Perez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R and Garza-Gonzalez E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 2005; 40: 56-60.
103. Chung WC, Lee KM, Lee BI, Chun JS, Lee SY, Chang UI, Park SH, Yang JM, Choi KY and Chung IS. P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med 2006; 21: 28-32.
104. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML and Wu XT. P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer 2007; 121: 1481-1486.
105. Chan AO. E-cadherin in gastric cancer. World J Gastroenterol 2006; 12: 199-203.
106. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-405.
107. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BA and Caldas C. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58: 4086-4089.
108. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-3852.
109. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M and et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991; 139: 17-23.
110. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P and Dahiya R. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000; 60: 873-876.
111. Gao L, Nieters A and Brenner H. Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment Pharmacol Ther 2008; 28: 565-573.